Survey of a community-based infusion program for Australian patients with rheumatoid arthritis requiring treatment with tocilizumab: Patient characteristics and drivers of patient satisfaction and patient-perceived benefits and concerns

Patient Preference and Adherence

Volumn 6, Issue , 2012, Pages 275-283

  Voight, Louisa ^a  

^a Coast Joint Care ^*  (Australia)

Author keywords

Arthritis; Health; Infusions; Intravenous; Patient satisfaction; Rheumatoid; Survey; Tocilizumab

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; TOCILIZUMAB;

ADULT; AGED; ARTICLE; AUSTRALIA; COMMUNITY BASED INFUSION PROGRAM; DEMOGRAPHY; DISABILITY; DISEASE DURATION; EXPERIENCE; FEMALE; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PATIENT SATISFACTION; RHEUMATOID ARTHRITIS; TREATMENT DURATION;

EID: 84874620801     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S29867     Document Type: Article

References (19)

1. National Centre for Monitoring Arthritis and Musculoskeletal Conditions. A Picture of Rheumatoid Arthritis in Australia. Cat no PHE 110. Canberra, Australia: Australian Institute of Health and Welfare; 2009.
2. Breedveld FC, Combe B. Understanding emerging treatment paradigms in rheumatoid arthritis. Arthritis Res Ther. 2011;13 Suppl 1:S3.
3. Saag KG, Teng GG, Patkar NM, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum. 2008;59(6):762-784.
4. Chatzidionysiou K, van Vollenhoven RF. When to initiate and discontinue biologic treatments for rheumatoid arthritis? J Intern Med. 2011;269(6):614-625.
5. Doran JP, Alraqi S, Callanan I, FitzGerald O, Bresnihan B, Veale DJ. An audit of hospital based outpatient infusions and a pilot program of community-based monoclonal antibody infusions. Ir J Med Sci. 2009;178(4):497-501.
6. van Eijk Y, Boonen A, Schulpen G, Schrijnemaekers V, Fiolet H, van der Linden S. Safety and patient satisfaction of infliximab administration in an extramural setting supervised by a rheumatology specialist nurse. Ann Rheum Dis. 2006;65(2):276.
7. Ratcliffe R, Bamford T, Palmer N, Volteas S, Newman J. Three years experience with a home infusion program for RA patients in Australia. Ann Rheum Dis. 2011;70 Suppl 3:618.
8. Jones G, Sebba A, Gu J, et al. Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study. Ann Rheum Dis. 2010;69(1):88-96.
9. Jones G, Ding C. Tocilizumab: a review of its safety and efficacy in rheumatoid arthritis. Clin Med Insights Arthritis Musculoskelet Disord. 2010;3:81-89.
10. Actemra (Prescribing information). Dee Why, NSW, Australia: Roche Products Pty Limited; 2011.
11. Fries JF, Spitz P, Kraines RC, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum. 1980;23(2):137-145.
12. Cole JC, Motivala SJ, Khanna D, Lee JY, Paulus HE, Irwin MR. Validation of single-factor structure and scoring protocol for the health assessment questionnaire-disability index. Arthritis Rheum. 2005;53(4):536-542.
13. Bruce B, Fries JF. The Stanford Health Assessment Questionnaire: dimensions and practical applications. Health Qual Life Outcomes. 2003;1:20.
14. Leffers HC, Ostergaard M, Glintborg B, et al. Efficacy of abatacept and tocilizumab in patients with rheumatoid arthritis treated in clinical practice: results from the nationwide Danish DANBIO registry. Ann Rheum Dis. 2011;70(7):1216-1222.
15. Chilton F, Collett RA. Treatment choices, preferences and decisionmaking by patients with rheumatoid arthritis. Musculoskeletal Care. 2008;6(1):1-14.
16. Scarpato S, Antivalle M, Favalli EG, et al. Patient preferences in the choice of anti-TNF therapies in rheumatoid arthritis. Results from a questionnaire survey (RIVIERA study). Rheumatology. 2010;49(2):289-294.
17. Nishimoto N, Ito K, Takagi N. Safety and efficacy profiles of tocilizumab monotherapy in Japanese patients with rheumatoid arthritis: meta-analysis of six initial trials and five long-term extensions. Mod Rheumatol. 2010;20(3):222-232.
18. Phillips J. Rheumatoid arthritis: bringing care closer to home. Br J Community Nurs. 2011;16:340.
19. Fincham JE. Response rates and responsiveness for surveys, standards, and the journal. Am J Pharm Educ. 2008;72:43.